1. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348:56–61.
2. Food and Drug Administration of USA. Principles for codevelopment of an in vitro companion diagnostic device with a therapeutic product. 2016
https://www.fda.gov/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/ucm407297.htm
. Accessed 8 Dec 2018.
3. Korean Ministry of Food and Drug Safety. Guideline for approval of medicines associated with companion diagnostic devices. 2018
http://www.nifds.go.kr/brd/m_15/view.do?seq=12442
. Accessed 8 Dec 2018.
4. Food and Drug Administration of USA. List of cleared or approved companion diagnostic devices (in vitro and imaging tools). 2018.
5. Prasad V. The withdrawal of drugs for commercial reasons: the incomplete story of tositumomab. JAMA Intern Med. 2014;174:1887–8.